Member Posts > Cardiol Therapeutics to Present Updates on Cardiac Research and Therapy Development at TD Cowen Conference
Cardiol Therapeutics Inc., a biopharmaceutical company focused on innovative treatments for inflammatory heart disease, will present at the TD Cowen 45th Annual Health Care Conference in Boston on March 5, 2025, at 11:10 AM EST.
The company is set to discuss its latest research and clinical development progress, emphasizing new approaches to treating heart disease through anti-inflammatory and anti-fibrotic therapies. Cardiol Therapeutics has made significant strides in cardiovascular research, previously sharing its research milestones at the Oppenheimer 35th Annual Healthcare Life Sciences Conference (February 2025). Additionally, CEO David Elsley delivered a company update at the Cantor Fitzgerald 2023 Global Healthcare Conference, detailing Cardiol's mission to redefine cardiovascular treatment.
Through continuous participation in leading healthcare conferences, Cardiol Therapeutics strengthens its role as a key innovator in cardiovascular medicine, working toward breakthrough therapies that improve patient care worldwide.

#CardiolTherapeutics #MedicalInnovation #HeartDiseaseResearch #BiotechNews #CardiovascularBreakthroughs